{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:01:06Z","timestamp":1769068866991,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.14283\/jpad.2024.129","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T10:44:32Z","timestamp":1719398672000},"page":"1759-1766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unveiling Potential Biomarkers in Cerebrospinal Fluid for Amyloid Pathological Positivity in Non-Demented Individuals"],"prefix":"10.1016","volume":"11","author":[{"given":"F.","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2024.129_bib2","doi-asserted-by":"crossref","first-page":"101580","DOI":"10.1016\/j.eclinm.2022.101580","article-title":"Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approach","volume":"51","author":"Nandi","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.14283\/jpad.2024.129_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.14283\/jpad.2024.129_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"issue":"2","key":"10.14283\/jpad.2024.129_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nature reviews Neuroscience"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13195-020-00621-6","article-title":"Longitudinal trajectories of Alzheimer's ATN biomarkers in elderly persons without dementia","volume":"12","author":"Tan","year":"2020","journal-title":"Alzheimer's research & therapy"},{"key":"10.14283\/jpad.2024.129_bib8","doi-asserted-by":"crossref","first-page":"102229","DOI":"10.1016\/j.arr.2024.102229","article-title":"Evolving therapeutic interventions for the management and treatment of Alzheimer's disease","volume":"95","author":"Ahmad","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"20","key":"10.14283\/jpad.2024.129_bib9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","article-title":"CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings","volume":"78","author":"Sepp\u00e4l\u00e4","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.14283\/jpad.2024.129_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/archneurol.2011.153","article-title":"Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology","volume":"68","author":"Wolk","year":"2011","journal-title":"Archives of neurology"},{"issue":"6","key":"10.14283\/jpad.2024.129_bib11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nature medicine"},{"key":"10.14283\/jpad.2024.129_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbi.2017.01.020","article-title":"Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults","volume":"62","author":"Popp","year":"2017","journal-title":"Brain, behavior, and immunity"},{"issue":"10","key":"10.14283\/jpad.2024.129_bib13","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","article-title":"Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis","volume":"76","author":"Dhiman","year":"2019","journal-title":"Cellular and molecular life sciences: CMLS"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer's disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"Journal of neuroinflammation"},{"issue":"712","key":"10.14283\/jpad.2024.129_bib15","doi-asserted-by":"crossref","first-page":"eadg4122","DOI":"10.1126\/scitranslmed.adg4122","article-title":"A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease","volume":"15","author":"Haque","year":"2023","journal-title":"Science translational medicine"},{"issue":"7","key":"10.14283\/jpad.2024.129_bib16","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/alz.12897","article-title":"Robustness of CSF A\u03b242\/40 and A\u03b242\/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes","volume":"19","author":"Leuzy","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.129_bib17","doi-asserted-by":"crossref","first-page":"1062937","DOI":"10.3389\/fonc.2023.1062937","article-title":"Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection","volume":"13","author":"van der Kroft","year":"2023","journal-title":"Frontiers in oncology"},{"issue":"24","key":"10.14283\/jpad.2024.129_bib18","doi-asserted-by":"crossref","first-page":"21861","DOI":"10.1002\/cam4.6757","article-title":"Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics","volume":"12","author":"Jiang","year":"2023","journal-title":"Cancer medicine"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer's disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer","year":"2022","journal-title":"Alzheimer's research & therapy"},{"issue":"3","key":"10.14283\/jpad.2024.129_bib20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00415-022-11476-2","article-title":"Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer's disease by integrated bioinformatics","volume":"270","author":"Li","year":"2023","journal-title":"Journal of neurology"},{"issue":"6","key":"10.14283\/jpad.2024.129_bib21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","article-title":"Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression","volume":"105","author":"Bai","year":"2020","journal-title":"Neuron"},{"issue":"11","key":"10.14283\/jpad.2024.129_bib22","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1093\/brain\/awad213","article-title":"CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease","volume":"146","author":"van der Ende","year":"2023","journal-title":"Brain: a journal of neurology"},{"key":"10.14283\/jpad.2024.129_bib23","author":"Montgomery"},{"issue":"2","key":"10.14283\/jpad.2024.129_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/cvr\/cvv098","article-title":"Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor \u03b2 signalling and angiogenesis","volume":"106","author":"Awwad","year":"2015","journal-title":"Cardiovascular research"},{"key":"10.14283\/jpad.2024.129_bib25","doi-asserted-by":"crossref","first-page":"106114","DOI":"10.1016\/j.nbd.2023.106114","article-title":"Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models","volume":"181","author":"Li","year":"2023","journal-title":"Neurobiology of disease"},{"key":"10.14283\/jpad.2024.129_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2022.12.003","article-title":"Vascular contributions to Alzheimer's disease","volume":"254","author":"Eisenmenger","year":"2023","journal-title":"Translational research: the journal of laboratory and clinical medicine"},{"issue":"6","key":"10.14283\/jpad.2024.129_bib27","doi-asserted-by":"crossref","first-page":"e13061","DOI":"10.1111\/bpa.13061","article-title":"Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives","volume":"32","author":"Fisher","year":"2022","journal-title":"Brain pathology (Zurich, Switzerland)"},{"issue":"9","key":"10.14283\/jpad.2024.129_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nature reviews Neurology"},{"issue":"12","key":"10.14283\/jpad.2024.129_bib29","doi-asserted-by":"crossref","first-page":"e11170","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO molecular medicine"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13195-022-01051-2","article-title":"Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease","volume":"14","author":"Prins","year":"2022","journal-title":"Alzheimer's research & therapy"},{"issue":"11","key":"10.14283\/jpad.2024.129_bib31","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41380-022-01716-2","article-title":"Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer's disease","volume":"27","author":"Ferrari-Souza","year":"2022","journal-title":"Molecular psychiatry"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","article-title":"YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies","volume":"14","author":"Querol-Vilaseca","year":"2017","journal-title":"Journal of neuroinflammation"},{"issue":"10","key":"10.14283\/jpad.2024.129_bib33","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/alz.12806","article-title":"Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability","volume":"18","author":"Simr\u00e9n","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.14283\/jpad.2024.129_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","article-title":"The dynamics of plasma biomarkers across the Alzheimer's continuum","volume":"15","author":"Guo","year":"2023","journal-title":"Alzheimer's research & therapy"},{"issue":"6","key":"10.14283\/jpad.2024.129_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tins.2023.03.005","article-title":"Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease","volume":"46","author":"Young-Pearse","year":"2023","journal-title":"Trends in neurosciences"},{"issue":"46","key":"10.14283\/jpad.2024.129_bib36","doi-asserted-by":"crossref","first-page":"eabo6764","DOI":"10.1126\/sciadv.abo6764","article-title":"Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity","volume":"8","author":"Iturria-Medina","year":"2022","journal-title":"Science advances"},{"issue":"4","key":"10.14283\/jpad.2024.129_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.14283\/jpad.2024.129_bib38","doi-asserted-by":"crossref","first-page":"106631","DOI":"10.1016\/j.phrs.2022.106631","article-title":"Role of monomeric amyloid-\u03b2 in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies","volume":"187","author":"Imbimbo","year":"2023","journal-title":"Pharmacological research"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724007052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724007052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:44:40Z","timestamp":1736477080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724007052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2274580724007052"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.129","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling Potential Biomarkers in Cerebrospinal Fluid for Amyloid Pathological Positivity in Non-Demented Individuals","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}